These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2571491)

  • 1. The identification and management of drug-seeking behavior in a medical center.
    Pankratz L; Hickam DH; Toth S
    Drug Alcohol Depend; 1989 Oct; 24(2):115-8. PubMed ID: 2571491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trainees as Agents of Change in the Opioid Epidemic: Optimizing the Opioid Prescription Practices of Surgical Residents.
    Chiu AS; Healy JM; DeWane MP; Longo WE; Yoo PS
    J Surg Educ; 2018; 75(1):65-71. PubMed ID: 28705485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative opioid prescribing: Getting it RIGHTT.
    Yorkgitis BK; Brat GA
    Am J Surg; 2018 Apr; 215(4):707-711. PubMed ID: 29454483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Minnesota Prescription Monitoring Program.
    Herman C
    Northwest Dent; 2011; 90(2):33-5. PubMed ID: 21667591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for potential prescription opioid misuse in a michigan medicaid population.
    Braker LS; Reese AE; Card RO; Van Howe RS
    Fam Med; 2009; 41(10):729-34. PubMed ID: 19882397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Narcotic pain relievers: are you using them correctly?
    Johns Hopkins Med Lett Health After 50; 2012 Nov; 24(10):1-2. PubMed ID: 23362527
    [No Abstract]   [Full Text] [Related]  

  • 9. Too much medicine?
    Williams B
    Tenn Med; 2006 Apr; 99(4):19-23. PubMed ID: 16704125
    [No Abstract]   [Full Text] [Related]  

  • 10. Beyond the paper trail: using technology to reduce escalating harms from opioid prescribing in Australia.
    Nicholas R; Roche A; Dobbin M; Lee N
    Aust N Z J Public Health; 2013 Apr; 37(2):139-47. PubMed ID: 23551472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription Drug Monitoring Program: Useful Tool or Government Control?
    Lilly JD
    Mo Med; 2017; 114(4):234-236. PubMed ID: 30228597
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescription drug monitoring through the Maine Office of Substance Abuse.
    Benak LD; Eccher D; McKinney RE; Smith CM
    J Forensic Nurs; 2007; 3(3-4):141-5. PubMed ID: 18027536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reasons for under-use of prescribed opioid medications by patients in pain.
    Lewis ET; Combs A; Trafton JA
    Pain Med; 2010 Jun; 11(6):861-71. PubMed ID: 20624241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid Knowledge and Prescribing Practices Among Obstetrician-Gynecologists.
    Madsen AM; Stark LM; Has P; Emerson JB; Schulkin J; Matteson KA
    Obstet Gynecol; 2018 Jan; 131(1):150-157. PubMed ID: 29215508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation of Opioid Prescribing Patterns among Patients undergoing Similar Surgery on the Same Acute Care Surgery Service of the Same Institution: Time for Standardization?
    Eid AI; DePesa C; Nordestgaard AT; Kongkaewpaisan N; Lee JM; Kongwibulwut M; Han K; Mendoza A; Rosenthal M; Saillant N; Lee J; Fagenholz P; King D; Velmahos G; Kaafarani HMA
    Surgery; 2018 Nov; 164(5):926-930. PubMed ID: 30049481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinician impression versus prescription drug monitoring program criteria in the assessment of drug-seeking behavior in the emergency department.
    Weiner SG; Griggs CA; Mitchell PM; Langlois BK; Friedman FD; Moore RL; Lin SC; Nelson KP; Feldman JA
    Ann Emerg Med; 2013 Oct; 62(4):281-9. PubMed ID: 23849618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect Of A "No Superuser Opioid Prescription" Policy On ED Visits And Statewide Opioid Prescription.
    Kahler ZP; Musey PI; Schaffer JT; Johnson AN; Strachan CC; Shufflebarger CM
    West J Emerg Med; 2017 Aug; 18(5):894-902. PubMed ID: 28874942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Opioid Prescribing Patterns in the United States and Japan: Primary Care Physicians' Attitudes and Perceptions.
    Onishi E; Kobayashi T; Dexter E; Marino M; Maeno T; Deyo RA
    J Am Board Fam Med; 2017; 30(2):248-254. PubMed ID: 28379832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Projecting the cost, utilization, and patient care impact of prescribing extended release non-abuse-deterrent opioids to chronic pain patients.
    Yenikomshian MA; White AG; Carson ME; Garrison LP; Oderda GM; Biskupiak JE; Hlavacek PR; Roland CL
    J Opioid Manag; 2017; 13(5):291-301. PubMed ID: 29199395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of abusable prescription drugs: the role of gender.
    Simoni-Wastila L
    J Womens Health Gend Based Med; 2000 Apr; 9(3):289-97. PubMed ID: 10787224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.